BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 38590519)

  • 21.
    Li HB; Xu ML; Xu XD; Tang YY; Jiang HL; Li L; Xia WJ; Cui N; Bai J; Dai ZM; Han B; Li Y; Peng B; Dong YY; Aryal S; Manandhar I; Eladawi MA; Shukla R; Kang YM; Joe B; Yang T
    Circ Res; 2022 Oct; 131(9):e120-e134. PubMed ID: 36164984
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Influenza Virus Infection Impairs the Gut's Barrier Properties and Favors Secondary Enteric Bacterial Infection through Reduced Production of Short-Chain Fatty Acids.
    Sencio V; Gallerand A; Gomes Machado M; Deruyter L; Heumel S; Soulard D; Barthelemy J; Cuinat C; Vieira AT; Barthelemy A; Tavares LP; Guinamard R; Ivanov S; Grangette C; Teixeira MM; Foligné B; Wolowczuk I; Le Goffic R; Thomas M; Trottein F
    Infect Immun; 2021 Aug; 89(9):e0073420. PubMed ID: 33820816
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Altered gut microbiota composition with antibiotic treatment impairs functional recovery after traumatic peripheral nerve crush injury in mice: effects of probiotics with butyrate producing bacteria.
    Rodenhouse A; Talukder MAH; Lee JI; Govindappa PK; O'Brien M; Manto KM; Lloyd K; Wandling GD; Wright JR; Chen See JR; Anderson SL; Lamendella R; Hegarty JP; Elfar JC
    BMC Res Notes; 2022 Feb; 15(1):80. PubMed ID: 35197129
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Probiotics protect against RSV infection by modulating the microbiota-alveolar-macrophage axis.
    Ji JJ; Sun QM; Nie DY; Wang Q; Zhang H; Qin FF; Wang QS; Lu SF; Pang GM; Lu ZG
    Acta Pharmacol Sin; 2021 Oct; 42(10):1630-1641. PubMed ID: 33495515
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Synergy and oxygen adaptation for development of next-generation probiotics.
    Khan MT; Dwibedi C; Sundh D; Pradhan M; Kraft JD; Caesar R; Tremaroli V; Lorentzon M; Bäckhed F
    Nature; 2023 Aug; 620(7973):381-385. PubMed ID: 37532933
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of Probiotic Supplementation on Short Chain Fatty Acids in the AppNL-G-F Mouse Model of Alzheimer's Disease.
    Kaur H; Golovko S; Golovko MY; Singh S; Darland DC; Combs CK
    J Alzheimers Dis; 2020; 76(3):1083-1102. PubMed ID: 32623399
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Differential modulation by Akkermansia muciniphila and Faecalibacterium prausnitzii of host peripheral lipid metabolism and histone acetylation in mouse gut organoids.
    Lukovac S; Belzer C; Pellis L; Keijser BJ; de Vos WM; Montijn RC; Roeselers G
    mBio; 2014 Aug; 5(4):. PubMed ID: 25118238
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sustained Dysbiosis and Decreased Fecal Short-Chain Fatty Acids after Traumatic Brain Injury and Impact on Neurologic Outcome.
    Opeyemi OM; Rogers MB; Firek BA; Janesko-Feldman K; Vagni V; Mullett SJ; Wendell SG; Nelson BP; New LA; Mariño E; Kochanek PM; Bayır H; Clark RSB; Morowitz MJ; Simon DW
    J Neurotrauma; 2021 Sep; 38(18):2610-2621. PubMed ID: 33957773
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Human-origin probiotic cocktail increases short-chain fatty acid production via modulation of mice and human gut microbiome.
    Nagpal R; Wang S; Ahmadi S; Hayes J; Gagliano J; Subashchandrabose S; Kitzman DW; Becton T; Read R; Yadav H
    Sci Rep; 2018 Aug; 8(1):12649. PubMed ID: 30139941
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Specific Strains of
    Hu W; Gao W; Liu Z; Fang Z; Wang H; Zhao J; Zhang H; Lu W; Chen W
    Nutrients; 2022 Jul; 14(14):. PubMed ID: 35889903
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Growth-promoting effect of alginate on Faecalibacterium prausnitzii through cross-feeding with Bacteroides.
    Murakami R; Hashikura N; Yoshida K; Xiao JZ; Odamaki T
    Food Res Int; 2021 Jun; 144():110326. PubMed ID: 34053530
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Faecalibacterium prausnitzii Produces Butyrate to Maintain Th17/Treg Balance and to Ameliorate Colorectal Colitis by Inhibiting Histone Deacetylase 1.
    Zhou L; Zhang M; Wang Y; Dorfman RG; Liu H; Yu T; Chen X; Tang D; Xu L; Yin Y; Pan Y; Zhou Q; Zhou Y; Yu C
    Inflamm Bowel Dis; 2018 Aug; 24(9):1926-1940. PubMed ID: 29796620
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Different effects of probiotics and antibiotics on the composition of microbiota, SCFAs concentrations and FFAR2/3 mRNA expression in broiler chickens.
    Zhang JM; Liu XY; Gu W; Xu HY; Jiao HC; Zhao JP; Wang XJ; Li HF; Lin H
    J Appl Microbiol; 2021 Aug; 131(2):913-924. PubMed ID: 33263216
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Co-Culture with
    Kim H; Jeong Y; Kang S; You HJ; Ji GE
    Microorganisms; 2020 May; 8(5):. PubMed ID: 32466189
    [No Abstract]   [Full Text] [Related]  

  • 35. F. prausnitzii and its supernatant increase SCFAs-producing bacteria to restore gut dysbiosis in TNBS-induced colitis.
    Zhou Y; Xu H; Xu J; Guo X; Zhao H; Chen Y; Zhou Y; Nie Y
    AMB Express; 2021 Feb; 11(1):33. PubMed ID: 33641084
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Abundance of Probiotics and Butyrate-Production Microbiome Manages Constipation via Short-Chain Fatty Acids Production and Hormones Secretion.
    Zhuang M; Shang W; Ma Q; Strappe P; Zhou Z
    Mol Nutr Food Res; 2019 Dec; 63(23):e1801187. PubMed ID: 31556210
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Human gut microbiome impacts skeletal muscle mass via gut microbial synthesis of the short-chain fatty acid butyrate among healthy menopausal women.
    Lv WQ; Lin X; Shen H; Liu HM; Qiu X; Li BY; Shen WD; Ge CL; Lv FY; Shen J; Xiao HM; Deng HW
    J Cachexia Sarcopenia Muscle; 2021 Dec; 12(6):1860-1870. PubMed ID: 34472211
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The role of probiotic intervention in regulating gut microbiota, short-chain fatty acids and depression-like behavior in lead-exposed rats.
    Chen X; Meng S; Yu Y; Li S; Wu L; Zhang Y
    Int J Occup Med Environ Health; 2022 Feb; 35(1):95-106. PubMed ID: 35143471
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Enhanced butyrate formation by cross-feeding between Faecalibacterium prausnitzii and Bifidobacterium adolescentis.
    Rios-Covian D; Gueimonde M; Duncan SH; Flint HJ; de los Reyes-Gavilan CG
    FEMS Microbiol Lett; 2015 Nov; 362(21):. PubMed ID: 26420851
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Reduced Abundance of Butyrate-Producing Bacteria Species in the Fecal Microbial Community in Crohn's Disease.
    Takahashi K; Nishida A; Fujimoto T; Fujii M; Shioya M; Imaeda H; Inatomi O; Bamba S; Sugimoto M; Andoh A
    Digestion; 2016; 93(1):59-65. PubMed ID: 26789999
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.